1. ANDRE L. MITCHELL, M.D.
501 SE 2nd
ST
#1303
Fort Lauderdale, FL 33301
Cell: 763.438.3554
Email: amitchell@mgh-corp.com
EDUCATION / TRAINING
Residency: Kansas University Hospital and Clinics, Department of
Radiation Oncology
Training Dates 07/2000 – 07/2004.
M.D., University of Missouri-Columbia School of Medicine, Columbia,
Missouri. 08/1993 – 05/1999.
B.S., Central Missouri State University, Warrensburg, Missouri.
Major: Biology Minor: Chemistry
Dates: 08/1988 – 05/1992.
AFFILIATATIONS & APPOINTMENTS
Coborn Cancer Center, Chairman/Cancer Conference Coordinator, 08/2007 –
04/2014
Coborn Cancer Center, Cancer Care Board Member, 08/2005 – 04/2014
EMPLOYMENT
Founder & Chief Executive Officer, Mitchell Global Holdings, Inc. 12/2013 - present
• Current leadership responsibilities are directly correlated with the success of the
organization.
• Integral role in establishing the mission, vision, and organizational goals
that ensure relevancy of the company within the community.
• Provide general oversight of the activities of the company.
• Serves as chief spokesman to assure proper representation of the
organization.
Radiation Oncologist, Coborn Cancer Center, CentraCare Health System,
8/05 – 4/2014
• During
my
9-­‐year
history
as
an
investigator
with
RTOG/NCI
I
maintained
perfect
treatment
planning
adherence
under
protocol
guidelines
(not
a
single
major
or
minor
protocol
deviation)

2. • Independently
developed
a
departmental
IV
hydration
and
nutrition
support
program
for
head
and
neck
cancer
patients
undergoing
combined
modality
management
that
reduced
hospitalization
rates
during
treatment
from
20%
to
less
than
1%
• During
my
tenure
I
was
reelected
7
consecutive
years
as
Chairman/Cancer
Conference
Coordinator
by
the
Cancer
Care
Board,
Coborn
Cancer
Center
• Broad
working
knowledge
and
utilization
of
EMR
(5+
years)
• Performed complete physical examinations during initial consultation and focused
exams while patients were receiving therapy.
• Collected a comprehensive medical and social history to include a review of all
body systems.
• Performed physical assessments in correlation with historical findings, records
and preliminary objective findings.
• Examined and ordered appropriate diagnostic tests and provided the necessary
treatment and/or medications as required.
• Referred selected cases to consultant specialists when necessary.
• Served as consulting physician to referral staff members regarding
radiation efficacy.
• Maintained intimate involvement in the review and approval of dosimetric plans
necessary for patient treatment.
• Facilitated patient care and management by support staff
• Maintained strong command of current medical literature supporting evidence
based best practices
• Educated patients and staff members on specific risk factors,
preventive/screening measures and genetic influences associated with
malignancies
• Registered Investigator with National Cancer Institute (NCI) – ensured
patient eligibility for various clinical trials, provided protocol oversight and
treatment compliance with protocol guidelines, submission of data regarding
treatment side effects and disease response
• Investigator with Radiation Therapy Oncology Group (RTOG) under NCI
Independent Contract Locum, CompHealth; 07/2004 – 06/2005
• Served as consulting physician to referral staff members regarding
radiation efficacy and treatment.
• Intimately involved in review and approval of dosimetric plans and
treatment.
• Member of Cyberknife team, St. Louis University – defined dose constraints and
dosimetric approval.
• Facilitated patient care and management by radiation support staff.

3. Medical Director, BioLife Plasma Services, Independence Missouri;
02/2004 – 01/2005
• Responsible for resolving medical issues regarding donor safety and
suitability.
• Mentor and educator to the medical supervisor and staff.
• Maintained working knowledge of SOPs, FDA, OSHA and CLIA
regulations.
Radiation Oncology Chief-Resident, Kansas University Medical Center; 07/2003 –
05/2004
• Liaison between attending staff and junior residents.
• Integral role in the development and structure of residency curriculum.
• Delegated patient management responsibilities to junior residents, nurses and
support staff.
Biotechnician, Innovex Incorporated, Lenexa, Kansas; 06/1992 – 07/1993
• Conducted platelet aggregation protocols for Phase II clinical trials
• Coordinated the dissemination of biological materials for clinical
evaluation.
• Bioanalysis and Pharmacokinetics
RESEARCH
1993 - 1994
Preceptor G. McDonald, Ph.D. Microbiology & Immunology. Project aim
was DNA purification of hemolytic mutants from Rickettsia rickettsii and
isolation of the hemolysin gene(s).
1996 – 1997
Preceptors V.H. Huxley, Ph.D., and D.J. Meyer, Jr. M.D., Ph.D., University
of Missouri Columbia. Investigated mesenteric capillary water
permeability following the administration of topical isoproterenol.
Presented research poster at the 1997 Experimental Biology meeting.
RADIATION THERAPY ONCOLOGY GROUP (RTOG) CLINICAL TRIALS
08/2005 – 04/2014
RTOG 0212 - A Phase II/III Randomized Trial of Two Doses (Phase III-Standard vs
High) and Two High Dose Schedules (Phase II-Once vs Twice Daily) for Delivering
Prophylactic Cranial Irradiation for Patients with Limited Disease Small Cell Lung
Cancer.
RTOG 0234 - A Phase II Randomized Trial of Surgery Followed by Chemoradiotherapy
Plus C225 (Cetuximab) For Advanced Squamous Cell Carcinoma of the Head and Neck.
RTOG 0525 - Phase III Trial Comparing Conventional Adjuvant Temozolomide with
Dose-Intensive Temozolomide in Patients with Newly Diagnosed Glioblastoma.

4. RTOG 0614 - A Randomized, Phase III, Double-Blind, Placebo-Controlled Trial of
Memantine for Prevention of Cognitive Dysfunction in Patients Receiving Whole-Brain
Radiotherapy.
RTOG 1012 - Phase II Randomized Trial of Prophylactic Manuka Honey for the
Reduction of Chemoradiation Therapy Induced Esophagitis-Related Pain During the
Treatment of Lung Cancer.
PRESENTATIONS
January 2008
Minnesota Family Practice Symposium. Contemporary Management
Approaches for Prostate Cancer.
January 2009
Third Thursday Medical Conference for the HealthCare Plaza. Part I
Management Trends in Locally Advanced Head and Neck Cancers.
February 2009
Third Thursday Medical Conference for the HealthCare Plaza. Part II
Management Trends in Locally Advanced Head and Neck Cancers.
LICENSING/CERTIFICATIONS
Minnesota Board of Medical Practice (active license - #47996)
Florida Board of Medicine (Being processed – anticipated active date July, 2015)
Florida Assisted Living Facility Administrator Core Training – completed April, 2015
Florida Assisted Living Facility Core Competency Certification – April, 2015
American Red Cross Adult First Aid/CPR Certification – May, 2015
PROFESSIONAL ORGANIZATIONS
Florida Medical Association (FMA) 2015 - active
American Medical Association (AMA) 1999 - 2015
American College of Radiology (ACR) 1999 - 2005
American Society of Clinical Oncology (ASCO) 2000 - 2004
Association of Residents in Radiation Oncology (ARRO) 2000 - 2004
American College of Radiation Oncology (ACRO) 2000 - 2005
American Society of Therapeutic Radiology Oncology (ASTRO)
American Brachytherapy Society (ABS) 2000 – 2005
VOLUNTEERISM/PHILANTHROPY
• Professional Mentorship – Lutheran Social Services of Minnesota, Training and
Education Center|Employment Services
• Bloomington Minnesota Chamber of Commerce – “Food in the Hood”|
Cedarcrest Church
• Minneapolis Regional Chamber of Commerce – Immersion Project| Center of
Changing Lives
• Benefactor and member - Walker Art Center Minneapolis